Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
View Top Employees from Immunome, Inc.Website | http://www.immunome.com/ |
Ticker | IMNM |
Revenue | $7.8 million |
Funding | $201.4 million |
Employees | 63 (58 on RocketReach) |
Founded | 2008 |
Address | 665 Stockton Drive Suite 300, Exton, Pennsylvania 19341, US |
Phone | (610) 321-3700 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Biotechnology |
Web Rank | 11 Million |
Keywords | Immunone, Immunome |
Competitors | Compass Therapeutics Inc., Eureka Therapeutics, Inc, Genelux, Kronos Bio, Leap Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Immunome, Inc. employee's phone or email?
The Immunome, Inc. annual revenue was $7.8 million in 2024.
Matt Robinson is the CTO of Immunome, Inc..
58 people are employed at Immunome, Inc..
Immunome, Inc. is based in Exton, Pennsylvania.
The NAICS codes for Immunome, Inc. are [54, 541714, 54171, 541, 5417].
The SIC codes for Immunome, Inc. are [87, 873].